Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Clinical trial NCT01942135 · COMPLETED
Trial details
- NCT number
- NCT01942135
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-26
- Primary completion
- 2014-12-05
- Enrollment
- 521
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.